Who is sponsoring NCT06314594?

NCT06314594 is sponsored by Hangzhou Medical College.

What drugs are being tested in NCT06314594?

Interventions in NCT06314594: Conventional treatment, intervention treatment.

What condition does NCT06314594 study?

NCT06314594 studies Adolescent Idiopathic Scoliosis (AIS).

Is NCT06314594 still recruiting?

NCT06314594 is currently recruiting now. Last updated 23 February 2026.

Last reviewed 2026-02-23 · How we verify

NCT06314594

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Personalized Prevention and Treatment Strategies for Adolescent Idiopathic Scoliosis Via a Comprehensive Health Management Platform

Recruiting now NA Last updated 23 February 2026

What this trial tests

NA trial testing Conventional treatment in Adolescent Idiopathic Scoliosis (AIS) in 76 participants. Currently enrolling.

Timeline

1 August 2025

Primary endpoint
1 December 2025

1 December 2026

Quick facts

Lead sponsor	Hangzhou Medical College
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	76
Start date	1 August 2025
Primary completion	1 December 2025
Estimated completion	1 December 2026
Sites	1 location across China

Drugs / interventions tested

Conventional treatment — full drug profile →
intervention treatment

Conditions studied

Adolescent Idiopathic Scoliosis (AIS) — all drugs for Adolescent Idiopathic Scoliosis (AIS) →

Sponsor

Hangzhou Medical College

Who can join

Adults 3 to 18, any sex, with Adolescent Idiopathic Scoliosis (AIS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Spinal cord injury (SCI), leads to functional deficits and complications like neurogenic bladder and deep vein thrombosis, imposing a global annual financial burden. This trial aims to compares Jiaji electroacupuncture (JEA) and scalp electroacupuncture (SEA) in SCI rehabilitation. This randomized controlled trial (RCT) compared JEA and SEA in SCI rehabilitation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Conventional treatment

Trials testing the same drug.

NCT07514949 — The Feasibility and Safety of RK-4 Injection Bypassing Blood-brain Barrier in the Treatment of Acute Large Hemispheric I · NA · not yet recruiting
NCT07518108 — The Role Of Fascia And Breathing Exercises In The Treatment Of Cervicogenic Headache · NA · not yet recruiting
NCT07495150 — Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis · NA · not yet recruiting
NCT07462169 — High Intensity Laser VS High Power Pain Threshold Ultrasound in Treatment of Plantar Fasciitis · NA · not yet recruiting
NCT07407088 — Effect of Virtual Reality-Supported Task-Oriented Training in Individuals With Rotator Cuff Lesions · NA · enrolling by invitation

Other recruiting trials for Adolescent Idiopathic Scoliosis (AIS)

Currently open trials in the same condition.

NCT07379593 — Validation of the Clinical Decision Support Systems (CDSS) Developed in the EU Horizon PREPARE Project in the Rehabilita · NA · active not recruiting
NCT06934278 — Pooled Human Plasma vs Crystalloid in The Management of Children Undergoing Instrumented Spinal Fusion for Scoliosis · Phase 3 · recruiting
NCT07045337 — Enhancing the Therapeutic Effect of Bracing for Adolescent Idiopathic Scoliosis With a Hybrid Bracing Protocol · NA · active not recruiting

Other Hangzhou Medical College trials

Trials by the same sponsor.

NCT06509841 — The Impact of Jiaji Electroacupuncture and Scalp Electroacupuncture on Traumatic Spinal Cord Injury · NA · completed
NCT06313866 — the Clinical Effect of TCM Sniffing Therapy Combined With Electroacupuncture in PSCI · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06314594 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hangzhou Medical College
Last refreshed: 23 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06314594.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing